Literature DB >> 4348752

The use of drugs in combination for the treatment of cancer: rationale and results.

V T DeVita, P S Schein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4348752     DOI： 10.1056/NEJM197305102881905

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  Tackling the problems of tumour chemotherapy by optimal drug scheduling.

Authors:  Ambili Remesh
Journal:  J Clin Diagn Res       Date:  2013-05-31

Review 2.  Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements.

Authors:  Shivanni Kummar; Helen X Chen; John Wright; Susan Holbeck; Myrtle Davis Millin; Joseph Tomaszewski; James Zweibel; Jerry Collins; James H Doroshow
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

3.  Small cell carcinoma: combined approach to treatment.

Authors:  A Gregor; P G Morgan; R L Morgan; F H Scadding; M Turner-Warwick
Journal:  Thorax       Date:  1979-12       Impact factor: 9.139

4.  Impact of new drugs and biologics on colorectal cancer treatment and costs.

Authors:  Pinar Karaca-Mandic; Jeffrey S McCullough; Mustaqeem A Siddiqui; Holly Van Houten; Nilay D Shah
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

5.  The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity.

Authors:  Susan L Holbeck; Richard Camalier; James A Crowell; Jeevan Prasaad Govindharajulu; Melinda Hollingshead; Lawrence W Anderson; Eric Polley; Larry Rubinstein; Apurva Srivastava; Deborah Wilsker; Jerry M Collins; James H Doroshow
Journal:  Cancer Res       Date:  2017-04-26       Impact factor: 12.701

Review 6.  Understanding resistance to combination chemotherapy.

Authors:  Justin R Pritchard; Douglas A Lauffenburger; Michael T Hemann
Journal:  Drug Resist Updat       Date:  2012-11-17       Impact factor: 18.500

7.  The chemotherapy of large-bowel cancer. Present status and future prospects.

Authors:  J Horton; C B Hacker; T J Cunningham; R W Sponzo
Journal:  Am J Dig Dis       Date:  1974-11

Review 8.  Cancer chemotherapy: new strategies for success.

Authors:  N A Berger
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

9.  Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity.

Authors:  P Skehan; J Thomas; S J Friedman
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

10.  Non-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapy.

Authors:  L Deonarine; B H Weinerman; B K MacDougall; S Kemel
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.